[Considerable improvement of spasticity and dystonic phenomena by sulfamethoxazole-trimethoprim in Joseph's disease].
Dehen
H
H
Sangla
S
S
De Broucker
T
T
Cheron
F
F
Cambier
J
J
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004421:Dystonia / Q000188:drug therapy; D006801:Humans; D008297:Male; D009128:Muscle Spasticity / Q000188:drug therapy; D013132:Spinocerebellar Degenerations / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000890:Anti-Infective Agents; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole
Amélioration considérable de la spasticité et des phénomènes dystoniques par le sulfaméthoxazole-triméthoprime au cours d'une maladie de Joseph.